Everolimus denied as not medically necessary by Kaiser Permanente?

Kaiser Permanente's specific coverage criteria for everolimus are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Kaiser Denies Everolimus on Medical-Necessity Grounds — and How to Appeal

Everolimus is used across multiple serious conditions, including certain cancers, tuberous sclerosis complex, and organ transplantation. A medical-necessity denial from Kaiser means a plan reviewer concluded the drug does not meet Kaiser's coverage criteria for the patient's specific diagnosis, disease stage, or treatment history. These denials are nearly always paperwork failures — the clinical justification exists in the chart but was not adequately surfaced in the prior authorization submission. A well-organized appeal that maps chart facts directly to each policy criterion routinely succeeds.

## The Federal Appeal Framework

Under ACA §2719, you have a right to internal appeal and then independent external review (IRO). The external review window is generally four months after final internal denial. For urgent or oncology cases, an expedited appeal compresses this to 72 hours.

For employer-sponsored self-funded plans, ERISA §503 applies: you are entitled to a full-and-fair review, written explanation of the denial citing the specific criteria used, and access to all clinical guidelines relied upon.

## Why Medical-Necessity Denials Are Appealable

Kaiser's medical-necessity criteria are derived from the FDA-approved prescribing label, recognized clinical compendia (such as NCCN), and professional society guidelines. When the appeal presents organized documentation showing the patient meets each published criterion — diagnosis, stage, prior therapy, performance status, and any other requirements — IRO reviewers applying objective clinical standards frequently reverse the denial.

## Documentation to Gather

• Confirmed diagnosis with pathology: Biopsy, imaging, pathology report, and any staging documentation relevant to the indication.
• Prior treatment history with outcomes: Dated pharmacy records, infusion logs, or office notes showing which therapies were tried before everolimus, how long they were used, and their clinical outcomes.
• Disease progression or severity documentation: Imaging reports, lab trends, performance status assessments, and any relevant clinical markers showing disease activity at the time of the request.
• Prescribing specialist's medical-necessity letter: A detailed letter that explicitly addresses each of Kaiser's published clinical criteria for everolimus, citing specific chart findings.
• FDA prescribing label: The current label showing the approved indication that matches this patient's exact diagnosis and situation.
• Applicable guideline reference: Reference (without citing statistics) to the applicable NCCN, ADA, or relevant specialty society guideline recommending this agent for this indication.

## Criteria-Mapping Structure

Build a table that places Kaiser's criteria directly next to the chart evidence:

| Kaiser Medical-Necessity Criterion for Everolimus | Chart Evidence (Date, Provider, Document) | |---|---| | [Copy verbatim from Kaiser's published clinical policy] | [Exact chart finding satisfying that criterion] |

Request Kaiser's clinical policy document if it was not attached to the denial — you are entitled to receive it. Match every criterion with a specific, dated chart entry.

## Practical Next Steps

1. Obtain the complete denial letter and the specific Kaiser clinical policy criteria applied. 2. Audit the original prior authorization submission against those criteria to identify documentation gaps. 3. Have the treating specialist draft a letter that addresses each criterion individually. 4. Attach the criteria-mapping table, pathology, imaging, and prior-therapy records. 5. File the internal appeal and, if denied, escalate promptly to independent external review.